Copenhagen Studies on Asthma in Childhood

Quick facts

Phase 2 pipeline

• Azithromycin Oral Liquid Product · Infectious diseases
  Azithromycin is a macrolide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Copenhagen Studies on Asthma in Childhood portfolio CI brief
• Copenhagen Studies on Asthma in Childhood pipeline updates RSS

Related

• Sector hub: All tracked pharma companies